Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan K Davis

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
Global Public Health|November 8, 2023
Exploring the intersectionality of stigma and substance use help-seeking behaviours among lesbian, gay, bisexual, transgender, queer, questioning or otherwise gender or sexuality minority (LGBTQ+) individuals in the United States: A scoping reviewYitong Xin, Corrine M Schwarting, Mary R Wasef, et al.
Implementation Research and Practice|February 2, 2026
Examining Interrelationships Between Implementation Outcomes in the Context of Traumatic Brain Injury Screening in Behavioral Health TreatmentKathryn A Hyzak, Alicia C Bunger, Jennifer A Bogner, et al.
The Journal of Head Trauma Rehabilitation|September 27, 2024
Identifying Barriers and Implementation Strategies to Inform TBI Screening Adoption in Behavioral Healthcare SettingsKathryn A Hyzak, Alicia C Bunger, Jennifer A Bogner, et al.
Journal of Psychoactive Drugs|January 11, 2022
Effects of Psychedelic Use on Racial Trauma Symptoms and Ethnic Identity among Asians in North AmericaTerence H W Ching, Alan K Davis, Yitong Xin, et al.
Addictive Behaviors|September 1, 2017
Recent cannabis use among Veterans in the United States: Results from a national sampleAlan K Davis, Lewei A Lin, Mark A Ilgen, et al.
Journal of Psychoactive Drugs|September 1, 2021
Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United StatesAlan K Davis, Gabrielle Agin-Liebes, Megan España, et al.
Journal of Psychoactive Drugs|January 10, 2022
Knowledge, Perceptions, and Use of Psychedelics among Individuals with FibromyalgiaNicolas G Glynos, Jennifer Pierce, Alan K Davis, et al.
Frontiers in Psychiatry|December 16, 2022
Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon's predictors and its emotional valenceAna María Ortiz Bernal, Charles L Raison, Rafael L Lancelotta, et al.
Journal of Psychopharmacology (Oxford, England)|May 1, 2018
The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumptionAlan K Davis, Joseph P Barsuglia, Rafael Lancelotta, et al.
The American Journal of Drug and Alcohol Abuse|March 2, 2019
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxietyAlan K Davis, Sara So, Rafael Lancelotta, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Global Public Health|November 8, 2023
Exploring the intersectionality of stigma and substance use help-seeking behaviours among lesbian, gay, bisexual, transgender, queer, questioning or otherwise gender or sexuality minority (LGBTQ+) individuals in the United States: A scoping reviewYitong Xin, Corrine M Schwarting, Mary R Wasef, et al.
Implementation Research and Practice|February 2, 2026
Examining Interrelationships Between Implementation Outcomes in the Context of Traumatic Brain Injury Screening in Behavioral Health TreatmentKathryn A Hyzak, Alicia C Bunger, Jennifer A Bogner, et al.
The Journal of Head Trauma Rehabilitation|September 27, 2024
Identifying Barriers and Implementation Strategies to Inform TBI Screening Adoption in Behavioral Healthcare SettingsKathryn A Hyzak, Alicia C Bunger, Jennifer A Bogner, et al.
Journal of Psychoactive Drugs|January 11, 2022
Effects of Psychedelic Use on Racial Trauma Symptoms and Ethnic Identity among Asians in North AmericaTerence H W Ching, Alan K Davis, Yitong Xin, et al.
Addictive Behaviors|September 1, 2017
Recent cannabis use among Veterans in the United States: Results from a national sampleAlan K Davis, Lewei A Lin, Mark A Ilgen, et al.
Journal of Psychoactive Drugs|September 1, 2021
Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United StatesAlan K Davis, Gabrielle Agin-Liebes, Megan España, et al.
Journal of Psychoactive Drugs|January 10, 2022
Knowledge, Perceptions, and Use of Psychedelics among Individuals with FibromyalgiaNicolas G Glynos, Jennifer Pierce, Alan K Davis, et al.
Frontiers in Psychiatry|December 16, 2022
Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon's predictors and its emotional valenceAna María Ortiz Bernal, Charles L Raison, Rafael L Lancelotta, et al.
Journal of Psychopharmacology (Oxford, England)|May 1, 2018
The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumptionAlan K Davis, Joseph P Barsuglia, Rafael Lancelotta, et al.
The American Journal of Drug and Alcohol Abuse|March 2, 2019
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxietyAlan K Davis, Sara So, Rafael Lancelotta, et al.
Pageof 10